Cargando…
Compound asset sharing initiatives between pharmaceutical companies, funding bodies, and academia: Learnings and successes
Over recent years, there have been several initiatives to gain access to compounds which have been deprioritized by pharmaceutical companies, but which have a data package allowing them to be used in human experimental medicine studies. Such compounds provide an invaluable resource for probing human...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664819/ https://www.ncbi.nlm.nih.gov/pubmed/31384472 http://dx.doi.org/10.1002/prp2.510 |